These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients. Zhou X; Sun D; Liu Y; Sun Q; Yuan Z; Luo X; Yang J; Chen J J Dermatolog Treat; 2020 Sep; 31(6):554-558. PubMed ID: 31116621 [No Abstract] [Full Text] [Related]
54. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report. Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604 [TBL] [Abstract][Full Text] [Related]
55. Fine needle aspiration cytology of dermatofibrosarcoma protuberans presenting as a breast mass. A case report. Zee SY; Wang Q; Jones CM; Abadi MA Acta Cytol; 2002; 46(4):741-3. PubMed ID: 12146044 [TBL] [Abstract][Full Text] [Related]
56. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. Prieto VG; Reed JA; Shea CR J Cutan Pathol; 1994 Aug; 21(4):324-9. PubMed ID: 7528229 [TBL] [Abstract][Full Text] [Related]
58. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement. Bague S; Folpe AL Am J Dermatopathol; 2008 Aug; 30(4):327-32. PubMed ID: 18645303 [TBL] [Abstract][Full Text] [Related]
60. Dermatofibrosarcoma Protuberans of the Breast in Man: An Extremely Rare Entity With a Review of the Literature. Bouhani M; Fertani Y; Zemni I; Adouni O; Bouida A; Chargui R; Khaled R J Investig Med High Impact Case Rep; 2019; 7():2324709619875634. PubMed ID: 31522558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]